De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures.

Nucleic Acids Research
Ramya RanganRhiju Das


The rapid spread of COVID-19 is motivating development of antivirals targeting conserved SARS-CoV-2 molecular machinery. The SARS-CoV-2 genome includes conserved RNA elements that offer potential small-molecule drug targets, but most of their 3D structures have not been experimentally characterized. Here, we provide a compilation of chemical mapping data from our and other labs, secondary structure models, and 3D model ensembles based on Rosetta's FARFAR2 algorithm for SARS-CoV-2 RNA regions including the individual stems SL1-8 in the extended 5' UTR; the reverse complement of the 5' UTR SL1-4; the frameshift stimulating element (FSE); and the extended pseudoknot, hypervariable region, and s2m of the 3' UTR. For eleven of these elements (the stems in SL1-8, reverse complement of SL1-4, FSE, s2m and 3' UTR pseudoknot), modeling convergence supports the accuracy of predicted low energy states; subsequent cryo-EM characterization of the FSE confirms modeling accuracy. To aid efforts to discover small molecule RNA binders guided by computational models, we provide a second set of similarly prepared models for RNA riboswitches that bind small molecules. Both datasets ('FARFAR2-SARS-CoV-2', Reading


Jun 27, 2003·Journal of Medicinal Chemistry·Susan L McGovern, Brian K Shoichet
Jan 28, 2004·Nucleic Acids Research·Tricia M ColemanFaqing Huang
Jan 5, 2005·PLoS Biology·Michael P RobertsonWilliam G Scott
Jul 29, 2006·Bioinformatics·Chuong B DoSerafim Batzoglou
Feb 22, 2008·Journal of Molecular Biology·Lichun LiDavid P Giedroc
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Ewan P Plant, Jonathan D Dinman
Jun 3, 2009·BMC Bioinformatics·Vincent Le GuillouxPierre Tuffery
Mar 17, 2010·BMC Bioinformatics·Jessica S Reuter, David H Mathews
May 13, 2011·Bioinformatics·Sungroh YoonRhiju Das
Jun 28, 2011·Nature Chemical Biology·Andrew C StelzerHashim M Al-Hashimi
Jan 1, 2013·Nucleic Acids Research·Daniella IshimaruMirko Hennig
Aug 24, 2013·RNA·Anton I PetrovNeocles B Leontis
Jan 23, 2014·Journal of the American Chemical Society·Dustin B RitchieMichael T Woodside
Mar 5, 2015·Virus Research·Dong Yang, Julian L Leibowitz
May 23, 2015·Nucleic Acids Research·Siqi TianRhiju Das
Jul 2, 2015·Nucleic Acids Research·Craig L ZirbelNeocles B Leontis
Apr 22, 2017·Journal of Chemical Theory and Computation·Rebecca F AlfordJeffrey J Gray
Jun 27, 2019·Methods in Enzymology·Andrew M WatkinsRhiju Das
Dec 5, 2019·Nature Communications·Kaiming ZhangWah Chiu
Mar 28, 2020·Journal of Medicinal Chemistry·Matthew G CostalesMatthew D Disney
Jun 13, 2020·Structure·Andrew Martin WatkinsRhiju Das
Jun 27, 2020·BioRxiv : the Preprint Server for Biology·Wes SandersNathaniel J Moorman
Oct 28, 2020·BioRxiv : the Preprint Server for Biology·Yu SunJunjie U Guo
Nov 10, 2020·Nucleic Acids Research·Ilaria ManfredoniaDanny Incarnato
Nov 10, 2020·Nucleic Acids Research·Anna WackerHeidi Zetzsche
Dec 9, 2020·Molecular Cell·Christiane IsermanAmy S Gladfelter

❮ Previous
Next ❯


May 28, 2021·Journal of the American Chemical Society·Sandro BottaroKresten Lindorff-Larsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.